secwatch.observer — SEC 8-K summary
======================================

Issuer:     SAFEGUARD SCIENTIFICS INC (SFES)
CIK:        0000086115
Form:       8-K
Filed at:   2022-08-11T23:59:59+00:00
Accession:  0001437749-22-020135
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Safeguard Scientifics reports Q2 net income of $0.5M; Moxe dilution gain; exploring strategic alternatives
--------------------------------------------------------------------------------

- Net income of $0.5M ($0.03/diluted EPS) vs net loss of $0.3M ($0.02 loss/share) in Q2 2021.
- Moxe raised $30M equity, diluting Safeguard's ownership to 19.4%, generating a $5.3M non-cash dilution gain.
- Repurchased 221,479 shares in Q2 at avg $4.27, totaling $0.9M; remaining authorization $1.1M.
- Continues working with Houlihan Lokey to explore strategic alternatives to maximize shareholder value.
- Expects 2022 corporate expenses at low-end or below $3.5-4.0M; deployments may hit upper half of $5-9M range.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/86115/000143774922020135/0001437749-22-020135-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/86115/000143774922020135/sfe20220525_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-020135

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer